The DOI matches its Crossref record; 29 of the 29 references it cites were found in a registry or an index.
Risks of breast and endometrial cancer after estrogen and estrogen–progestin replacement
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
McCullagh, P., & Nelder, J. A. (1989) · doi:10.1007/978-1-4899-3242-6 · Cited by 16,836
EPIDEMIOLOGY OF OSTEOPOROSIS AND OSTEOPOROTIC FRACTURES
CUMMINGS, S. R., KELSEY, J. L., NEVITT, M. C., & O'DOWD, K. J. (1985) · Epidemiologic Reviews · doi:10.1093/oxfordjournals.epirev.a036281 · Cited by 1,705
Stampfer, M. J., & Colditz, G. A. (1991) · Preventive Medicine · doi:10.1016/0091-7435(91)90006-p · Cited by 1,600
The use of estrogens and progestins and the risk of breast cancer in postmenopausal women.
Colditz, G. A., Hankinson, S. E., Hunter, D. J., Willett, W. C., Manson, J. E., Stampfer, M. J., Hennekens, C., Rosner, B., & Speizer, F. E. (1995) · New England Journal of Medicine · doi:10.1056/nejm199506153322401 · Cited by 1,487 · cited 2×
“For breast cancer, long-term intake of non-contraceptive estrogens has been associated with a slightly increased risk in several [4±12], but not all [13±15], studies; among the studies reporting on the effect of combined treatment, some indicate a possibly enhanced [4, 10, 12, 16] or similar [6, 8] risk increase, or n…”
BackgroundResultEstrogens, Progestogens, Normal Breast Cell Proliferation, and Breast Cancer Risk
Pike, M. C., Spicer, D. V., Dahmoush, L., & Press, M. F. (1993) · Epidemiologic Reviews · doi:10.1093/oxfordjournals.epirev.a036102 · Cited by 1,010
Breast cancer screening with mammography: overview of Swedish randomised trials
Nyström, L., Wall, S., Rutqvist, L. E., Lindgren, A., Lindqvist, M., Rydén, S., Andersson, J., Bjurstam, N., Fagerberg, G., Frisell, J., et al. (1993) · The Lancet · doi:10.1016/0140-6736(93)91067-v · Cited by 968
Hormone replacement therapy and endometrial cancer risk: A meta-analysis
GRADY, D., GEBRETSADIK, T., KERLIKOWSKE, K., ERNSTER, V, & PETITTI, D. (1995) · Obstetrics & Gynecology · doi:10.1016/0029-7844(94)00383-o · Cited by 962
The Risk of Breast Cancer after Estrogen and Estrogen–Progestin Replacement
Bergkvist, L., Adami, H.-O., Persson, I., Hoover, R., & Schairer, C. (1989) · New England Journal of Medicine · doi:10.1056/nejm198908033210505 · Cited by 613
Self-citationKey, T., & Pike, M. (1988) · British Journal of Cancer · doi:10.1038/bjc.1988.44 · Cited by 547
Beresford, S. A., Weiss, N. S., Voigt, L. F., & McKnight, B. (1997) · The Lancet · doi:10.1016/s0140-6736(96)07365-5 · Cited by 446
Persson, I., Adami, H. O., Bergkvist, L., Lindgren, A., Pettersson, B., Hoover, R., & Schairer, C. (1989) · BMJ · doi:10.1136/bmj.298.6667.147 · Cited by 403
Self-citationStanford, J. L. (1995) · JAMA: The Journal of the American Medical Association · doi:10.1001/jama.1995.03530020055032 · Cited by 339
Persson, I., Yuen, J., Bergkvist, L., & Schairer, C. (1996) · International Journal of Cancer · doi:10.1002/(sici)1097-0215(19960729)67:3<327::aid-ijc4>3.0.co;2-t · Cited by 334
Self-citationEstrogen-Progestin Replacement Therapy and Endometrial Cancer
Pike, M. C., Peters, R. K., Cozen, W., Probst-Hensch, N. M., Wan, P. C., Mack, T. M., & Felix, J. C. (1997) · JNCI Journal of the National Cancer Institute · doi:10.1093/jnci/89.15.1110 · Cited by 315
Measuring the impact of menopausal symptoms on quality of life.
Daly, E., Gray, A., Barlow, D., McPherson, K., Roche, M., & Vessey, M. (1993) · BMJ · doi:10.1136/bmj.307.6908.836 · Cited by 312
HUNT, K., VESSEY, M., MCPHERSON, K., & COLEMAN, M. (1987) · BJOG: An International Journal of Obstetrics & Gynaecology · doi:10.1111/j.1471-0528.1987.tb03166.x · Cited by 288
Progestagen supplementation of exogenous oestrogens and risk of endometrial cancer
Voigt, L. F., Weiss, N. S., Chu, J., Daling, J. R., McKnight, B., & van Belle, G. (1991) · The Lancet · doi:10.1016/0140-6736(91)90417-n · Cited by 276
Effect of Estrogen Replacement Therapy on the Specificity and Sensitivity of Screening Mammography
Laya, M. B., Larson, E. B., Taplin, S. H., & White, E. (1996) · JNCI Journal of the National Cancer Institute · doi:10.1093/jnci/88.10.643 · Cited by 243
Persson, I., Thurfjell, E., & Holmberg, L. (1997) · Journal of Clinical Oncology · doi:10.1200/jco.1997.15.10.3201 · Cited by 187
Self-citationCline, J. M., Soderqvist, G., von Schoultz, E., Skoog, L., & von Schoultz, B. (1996) · American Journal of Obstetrics and Gynecology · doi:10.1016/s0002-9378(96)70379-4 · Cited by 163
Schairer, C., Byrne, C., Keyl, P. M., Brinton, L. A., Sturgeon, S. R., & Hoover, R. N. (1994) · Cancer Causes & Control · doi:10.1007/bf01831376 · Cited by 138
Self-citationLong-term Hormone Replacement Therapy and Risk of Breast Cancer in Postmenopausal Women
Newcomb, P. A., Longnecker, M. P., Storer, B. E., Mittendorf, R. L., Baron, J. A., Clapp, R., Bogdan, G., & Willett, W. C. (1995) · American Journal of Epidemiology · doi:10.1093/oxfordjournals.aje.a117717 · Cited by 137
Menopausal Hormone Use and Endometrial Cancer, by Tumor Grade and Invasion
Shapiro, J. A., Weiss, N. S., Beresford, S. A. A., & Voigt, L. F. (1998) · Epidemiology · doi:10.1097/00001648-199801000-00020 · Cited by 121
Estrogens, Progesterone, and Endometrial Cancer
Jick, S. S., Walker, A. M., & Jick, H. (1993) · Epidemiology · doi:10.1097/00001648-199301000-00005 · Cited by 83
Noncontraceptive hormone use and risk of breast cancer
Yang, C. P., Daling, J. R., Band, P. R., Gallagher, R. P., White, E., & Weiss, N. S. (1992) · Cancer Causes & Control · doi:10.1007/bf00051360 · Cited by 66
Persson, I. R., Bergkvist, L., Lindgren, C., & Yuen, J. E. (1997) · Journal of Clinical Epidemiology · doi:10.1016/s0895-4356(97)00004-8 · Cited by 40
Self-citationPersson, I., Adami, H., Johansson, E. D. B., LINDBERG, B. S., Manell, P., & Westerholm, B. (1983) · European Journal of Clinical Pharmacology · doi:10.1007/bf00542350 · Cited by 29
Self-citationVenkatesh (1989) · doi:10.1002/1097-0142(19890801)64:3
Cited by
Papaioannou, A., Morin, S., Cheung, A. M., Atkinson, S., Brown, J. P., Feldman, S., Hanley, D. A., Hodsman, A., Jamal, S. A., Kaiser, S. M., et al. (2010) · Canadian Medical Association Journal · doi:10.1503/cmaj.100771 · Cited by 1,749
Estrogen and the Risk of Breast Cancer
Clemons, M., & Goss, P. (2001) · New England Journal of Medicine · doi:10.1056/nejm200101253440407 · Cited by 1,096
Menopausal Estrogen and Estrogen-Progestin Replacement Therapy and Breast Cancer Risk
Schairer, C. (2000) · JAMA · doi:10.1001/jama.283.4.485 · Cited by 1,048
Self-citationSmith, R. A., von Eschenbach, A. C., Wender, R., Levin, B., Byers, T., Rothenberger, D., Brooks, D., Creasman, W., Cohen, C., Runowicz, C., et al. (2001) · CA: A Cancer Journal for Clinicians · doi:10.3322/canjclin.51.1.38 · Cited by 821
Differential Gene Regulation by the Two Progesterone Receptor Isoforms in Human Breast Cancer Cells
Richer, J. K., Jacobsen, B. M., Manning, N. G., Abel, M. G., Horwitz, K. B., & Wolf, D. M. (2002) · Journal of Biological Chemistry · doi:10.1074/jbc.m110090200 · Cited by 572
Metadata
- Authors
- Persson, I., Weiderpass, E., Bergkvist, L., Bergström, R., & Schairer, C.
- Venue
- Cancer Causes & Control
- Published
- 1999-07
- Volume
- 10
- Issue
- 4
- Pages
- 253-260
- ISSN
- 0957-5243 (ISSN-L)
- 1573-7225
- OpenAlex
- W1599864597
- Cited by
- 258
- References
- 29
- FWCI
- 15.74
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.